Please provide your email address to receive an email when new articles are posted on . Active, percutaneous peripheral nerve stimulation reduced pain scores and opioid requirements without side ...
Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
POMPANO BEACH, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, proudly introduces ...
Please provide your email address to receive an email when new articles are posted on . Published results showed percutaneous peripheral nerve stimulation may provide clinically meaningful and ...
(MENAFN- GlobeNewsWire - Nasdaq) POMPANO BEACH, Fla., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”) a Carlsbad, California-based company that markets a minimally invasive neurostimulation implant for the management of chronic intractable ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.
Centennial Spine and Pain joined us at the New Mexico Living studio on Monday for our weekly health segment. This week, Dr. John Watkins told us all about peripheral nerve stimulators – what they are, ...
The 24-month results of the COMFORT Peripheral Nerve Stimulation (PNS) RCT were published on January 23, 2026 in the peer-reviewed journal Chronic Pain & Management and are available here. These ...
SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results